EASTMAN CHEMICAL CO
For the period ended Jun 30, 2025. Filed Aug 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 1, 2025
EMN$65.45+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Consolidated Statements of Cash Flows
Table of Contents
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
| First Six Months | ||
|---|---|---|
| (Dollars in millions) | 2025 | 2024 |
| Operating activities | ||
| Net earnings | $323 | $396 |
| Adjustments to reconcile net earnings to net cash used in operating activities: | ||
| Depreciation and amortization | 253 | 253 |
| Benefit from deferred income taxes | (48) | (37) |
| Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: | ||
| (Increase) decrease in trade receivables | (183) | (138) |
| (Increase) decrease in inventories | (131) | (238) |
| Increase (decrease) in trade payables | (155) | 89 |
| Pension and other postretirement contributions (in excess of) less than expenses | (17) | (29) |
| Variable compensation payments (in excess of) less than expenses | (86) | (20) |
| Other items, net | 110 | 75 |
| Net cash provided by operating activities | 66 | 351 |
| Investing activities | ||
| Additions to properties and equipment | (297) | (300) |
| Government incentives | 14 | — |
| Other items, net | 5 | — |
| Net cash used in investing activities | (278) | (300) |
| Financing activities | ||
| Net increase in commercial paper and other borrowings | 344 | — |
| Proceeds from borrowings | 246 | 742 |
| Repayment of borrowings | (550) | (541) |
| Dividends paid to stockholders | (191) | (190) |
| Treasury stock purchases | (50) | (100) |
| Other items, net | (13) | 10 |
| Net cash used in financing activities | (214) | (79) |
| Effect of exchange rate changes on cash and cash equivalents | 12 | (6) |
| Net change in cash and cash equivalents | (414) | (34) |
| Cash and cash equivalents at beginning of period | 837 | 548 |
| Cash and cash equivalents at end of period | $423 | $514 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.